Internal Server Error

Exposome - About the company

Exposome is a seed company based in Mumbai (India), founded in 2020 by Prerna Sonthalia Goradia, Amit Goradia, Anish Sengupta and Ashish Daga. It operates as a Provider of materials chemistry solutions for industrial air and water treatment. Exposome has raised $4.04M in funding from Colossa Ventures and Bhukhanvala Group, with a current valuation of $*****. The company has 1373 active competitors, including 110 funded and 73 that have exited. Its top competitors include companies like Gradiant, Cambrian Innovation and Numat.

Company Details

Provider of materials chemistry solutions for industrial air and water treatment. The company offers products for air treatment, water treatment, and energy solutions across multiple industries. These industries include electronics, pharmaceuticals, oil and gas, public utilities, and renewable energy. The company’s solutions address industrial recovery, gas separation, and waste water compliance.
Email ID
*****@exposome.in
Phone Number
+91 **********
Registered Address
Plot No. 44, Ground Floor, The Marol Co-operative Industrial Estate LTD, Marol Bhavan, M.V. Road, Marol, Andheri East, Mumbai, Marol Bazar, Mumbai, Mumbai, Maharashtra, India, 400059
Key Metrics
Founded Year
2020
Location
Mumbai, India
Stage
Seed
Total Funding
$4.04M in 5 rounds
Latest Funding Round
Post Money Valuation
$***** as on Jul 24, 2025
Ranked
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2026
Employee Count
28 as on Jan 31, 2025
Similar Companies
Sign up to download Exposome's company profile

Exposome's funding and investors

Exposome has raised a total funding of $4.04M over 5 rounds. Its first funding round was on Sep 03, 2022. Its latest funding round was a Seed round on Oct 13, 2025 for $*****. 7 investors participated in its latest round. Exposome has 10 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of Exposome:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Oct 13, 2025
6384768
Seed
5448833
7259568
5988763
8409237
Sep 10, 2024
7095024
Seed
5539351
4086247
8898493
Aug 28, 2023
4192319
Seed
9307058
7535528
4322304
lockAccess funding benchmarks and valuations. Sign up today!

Exposome's founders and board of directors

Founder? Claim Profile
Here are the details of Exposome's key team members:

Exposome's Board of Directors

Exposome's board has 2 active members. Prerna Sonthalia Goradia is part of team and Amit Yogesh Goradia is independent board member.
Here is the list of Exposome's board of directors:
Name
Type
Representing
Status
Duration
Team
-
Current
6y 4m
Independent board member
-
Current
6y 4m

Exposome's employee count trend

Exposome has 28 employees as of Jan 25. Here is Exposome's employee count trend over the years:
Employee count trend for Exposome
lockUncover Exposome's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Exposome's Competitors and alternates

Top competitors of Exposome include Gradiant, Cambrian Innovation and Numat. Here is the list of Top 10 competitors of Exposome, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Gradiant
Gradiant
2013, Woburn (United States), Series E
Provider of industrial water treatment solutions and technologies
$400M
72/100
2nd
Logo for Cambrian Innovation
Cambrian Innovation
2006, Boston (United States), Series C
Bio-electro-chemical wastewater treatment systems developer
$237M
63/100
3rd
Logo for Numat
Numat
2013, Skokie (United States), Series B
Developer of metal-organic framework solutions for chemical capture and separation
$21.4M
63/100
4th
Logo for Epic Cleantec
Epic Cleantec
2015, San Francisco (United States), Series B
Provider of wastewater infrastructure development services
$24M
62/100
5th
Logo for Xylem Water Solutions
Xylem Water Solutions
1924, New York City (United States), Public
Provider of water and wastewater treatment systems, solutions, and related services
-
61/100
6th
Logo for Claros Technologies
Claros Technologies
2015, Saint Paul (United States), Series B
Provider of sustainable solutions for circular economy
$113M
61/100
7th
Logo for Circular Materials
Circular Materials
2019, Cambiago (Italy), Series B
Technology solution for wastewater treatment
$13.5M
59/100
8th
Logo for Soiltech
Soiltech
2011, Tananger (Norway), Public
Provider of technologies for treatment, recycling, and handling of industrial waste
-
58/100
9th
Logo for Aqua Membranes
Aqua Membranes
2011, Albuquerque (United States), Series B
Developer of open channel membrane systems
$39M
58/100
10th
Logo for Energy Recovery
Energy Recovery
1992, San Leandro (United States), Public
Energy efficiency solutions for desalination, wastewater, and CO2 refrigeration industries
$5M
58/100
53rd
Logo for Exposome
Exposome
2020, Mumbai (India), Seed
Provider of materials chemistry solutions for industrial air and water treatment
$4.04M
44/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Exposome's competitors? Click here to see the top ones

Financials of ExposomeFY 26 Available

EXPOSOME PRIVATE LIMITED, the legal entity associated with Exposome, generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2026. The revenue of EXPOSOME PRIVATE LIMITED has a compounded annual growth rate (CAGR) of 36% in the last 1 year.

Financial Statement Summary

Metrics
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
Income Statement
Revenue
2908
1074
2502
2592
6497
Total Sales
8186
4676
2816
3865
5517
Total Expenses
7524
2610
1683
1661
1789
Operating Expenses
3672
2544
8238
2567
6699
Employee Expenses
4287
2182
4650
8016
7344
Operating Income (EBIT)
1725
6854
8255
4321
9893
Interest Expenses
2573
6396
4735
8085
6529
Expenses from other activities
1160
5465
7111
3093
7230
EBITDA
4398
1741
8331
2922
9730
Taxes
6558
6945
3455
1874
7740
Net Profit
6544
7006
2523
2987
1328
Balance Sheet
Assets
5858
2811
1273
3648
6318
Accounts Receivables
8432
3882
2507
4975
9297
Inventory
5413
1058
2342
6524
8815
Liabilities
9325
2321
6217
1633
3001
Total Debt
7050
9571
1907
8825
4984
Accounts Payable
2573
3266
2741
2812
4633
Equities
6574
9701
4879
2454
5341

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Gain deeper financial insights
of this entity
$10.99$2.53(excl. taxes)
Download Sample Report
What documents will you get?
  • Financial Summary & Charts
  • Detailed Income Statement, Balance Sheet, Cashflow Statement
  • Profitability Ratios, Liquidity Ratios, Growth Rates

Exposome's Latest cap tables and shareholding

Founders (largest shareholder) own 71.59%, Funds own 11.54%, Enterprises own 0.36% and Angels own 1.73%. The net worth of Exposome's founders is INR 62.4Cr as of Dec 16, 2024. The cap table displayed below is for EXPOSOME PRIVATE LIMITED which is the legal entity associated with Exposome.
Shareholders Name
Post Round Holding %
Net worth
Cumulative Investment
Realised Returns
Unrealised Returns
Return Multiple
Founder
71.59%
62.4Cr
1588766
3431980
9252417
6467088
7386477
7346641
4278368
4478477
7065029
7979177
Fund
11.54%
10.1Cr
8745497
8662532
4846235
8136675
68446
44307
96171
71309
21024
16176
44
74
26
25
50
66
4
5
3
8
2
6
Enterprise
0.36%
31.2L
0
0
0
0
Angel
1.73%
1.5Cr
7
6
6
8
7
4
4
3
6
7
ESOP Pool
14.63%
12.8Cr
5865260
2231874
5810242
8426937
Other Investors
0.14%
12.5L
0
0
0
0
Total
99.99%
87.1Cr
7445324
1812112
7677031
4936143
Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
Disclaimer
Gain deeper insights into
shareholding pattern of this entity
$9.99$4.23(excl. taxes)
Download Sample Files
What documents will you get?
  • Latest Shareholding Summary - Ownership breakdown across founders, investors, and other stakeholders
  • Round-by-Round Cap Tables - Evolution of shareholding across funding rounds
  • Year-on-Year Cap Tables - Dilution trends over time

Exposome's Investments and acquisitions

Exposome has made no investments or acquisitions yet.

Reports related to Exposome

Here is the latest report on Exposome's sector:

News related to Exposome

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Exposome

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford